Comment: Critical quality attributes of biosimilars

Bookmark and Share
Published: 8 Oct 2019
Views: 1166
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Prof Arnold Vulto speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about the critical quality attributes (CQA) of pharmacological agents.

He explains that these agents emit various functions - which can now be compared between the originator product and the biosimilar.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.